Table 3 Benefits of the effect of clinical trial therapy as compared with conventional treatment

From: Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives

Variable ( N)

Benefit (mean±s.d.)

P -value

Sex

  

 Male (184)

0.74±2.07

0.002a

 Female (244)

0.11±2.07

 

Age (years)

  

30 (11)

1.18±1.47

0.709b

 30< to 40 (51)

0.41±2.09

 

 40< to 50 (108)

0.19±2.15

 

 50< to 60 (106)

0.31±2.32

 

 60< to 70 (118)

0.43±1.78

 

 70< to (34)

0.73±2.28

 

Line

  

 Neoadjuvant (20)

−0.12±1.71

0.001b

 Adjuvant (151)

−0.10±2.36

 

 Metastatic, first line (121)

0.47±1.62

 

 Metastatic, second line (58)

0.58±1.77

 

 Metastatic, third line (38)

0.77±2.21

 

 Metastatic, fourth line (20)

1.25±1.65

 

 Metastatic, fifth line (10)

1.70±2.35

 

 Metastatic, sixth line (8)

2.00±3.33

 

 Metastatic, seventh line (2)

2.00±2.82

 

Marital status

  

 Single (28)

1.14±1.26

0.028b

 Married (353)

0.38±2.11

 

 Bereavement (23)

−0.47±2.23

 

 Divorced (15)

1.00±1.13

 

Educational degree

  

 Postgraduate (34)

0.32±1.42

0.92b

 University (135)

0.32±2.24

 

 High school (152)

0.53±1.96

 

 Middle school (44)

0.31±2.34

 

 Elementary school (41)

0.31±1.91

 

 Uneducated (7)

−0.14±2.54

 

Economic status

  

 >5c (55)

0.36±1.97

0.847b

 5 to >4 (40)

0.07±2.11

 

 4 to >3 (68)

0.33±2.46

 

 3 to >2 (51)

0.52±1.75

 

 2 to >1 (79)

0.60±1.73

 

 1 (104)

0.41±2.25

 

Religion

  

 Buddhism (130)

0.37±2.29

0.717b

 Christian (129)

0.22±2.03

 

 Catholicism (64)

0.59±2.02

 

 Others (65)

0.40±2.04

 

Private cancer insurance

  

 Yes (207)

0.16±2.25

0.043a

 No (203)

0.58±1.90

 

Distance from Clinic

  

2 h (288)

0.49±1.87

0.129a

 >2 h (140)

0.16±2.46

 

Awareness of clinical trial

  

 Yes (366)

0.40±2.12

0.631a

 No (62)

0.26±1.95

 
  1. at-test.
  2. bOne-way analysis of variances.
  3. cThousands United States dollars per month.